Stock Price CHF: 1.69
as of May 15, 2012
NAV CHF: 5.47
Performance yr to date:  -14.21%
Performance since IPO, Oct. 17, 1997:  -94.88%

NAV History

Ticker
Telekurs (NEV)
Reuters (NEV.S)
Bloomberg (NEV SW)

May 18, 2012 – Osiris receives marketing clearance from Health Canada for Prochymal
Click to download >>

May 15, 2012 – New Venturetec Semi-Annual Results 2012
Click to download >>

April 2, 2012 – New Venturetec Results expectation for the first half of the fiscal year 2011/21
Click to download >>

December 2 , 2011 – Shareholders unanimously approved all proposals of the Board at the AGM
Click to download >>

Publication of the Semi-Annual Report 2011/2012 as of March 31, 2012: May 16, 2012

Publication of the Annual Report 2011/2012 as of September 30, 2012: November 7, 2012

Annual Shareholders Meeting 2012: December 3, 2012